|
1
|
Parray A, Gupta V, Chaudhari VA,
Shrikhande SV and Bhandare MS: Role of intraperitoneal chemotherapy
in gastric cancer. Surg Prac Sci. 4(100025)2021.
|
|
2
|
Thomassen I, van Gestel YR, van Ramshorst
B, Luyer MD, Bosscha K, Nienhuijs SW, Lemmens VE and de Hingh IH:
Peritoneal carcinomatosis of gastric origin: A population-based
study on incidence, survival and risk factors. Int J Cancer.
134:622–628. 2014.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Yoo CH, Noh SH, Shin DW, Choi SH and Min
JS: Recurrence following curative resection for gastric carcinoma.
Br J Surg. 87:236–242. 2000.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Sadeghi B, Arvieux C, Glehen O, Beaujard
AC, Rivoire M, Baulieux J, Fontaumard E, Brachet A, Caillot JL,
Faure JL, et al: Peritoneal carcinomatosis from non-gynecologic
malignancies: Results of the EVOCAPE 1 multicentric prospective
study. Cancer. 88:358–363. 2000.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Boku N: Gastrointestinal Oncology Study
Group of Japan Clinical Oncology Group. Chemotherapy for metastatic
disease: Review from JCOG trials. Int J Clin Oncol. 13:196–200.
2008.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Mezhir JJ, Shah MA, Jacks LM, Brennan MF,
Coit DG and Strong VE: Positive peritoneal cytology in patients
with gastric cancer: Natural history and outcome of 291 patients.
Indian J Surg Oncol. 2:16–23. 2011.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Maeda H, Kobayashi M and Sakamoto J:
Evaluation and treatment of malignant ascites secondary to gastric
cancer. World J Gastroenterol. 21:10936–10947. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Glehen O, Mohamed F and Gilly FN:
Peritoneal carcinomatosis from digestive tract cancer: New
management by cytoreductive surgery and intraperitoneal
chemohyperthermia. Lancet Oncol. 5:219–228. 2004.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Brenkman HJ, Päeva M, van Hillegersberg R,
Ruurda JP and Haj Mohammad N: Pro-phylactic hyperthermic
intraperitoneal chemotherapy (HIPEC) for gastric cancer-a
systematic review. J Clin Med. 8(1685)2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Desiderio J, Chao J, Melstrom L, Warner S,
Tozzi F, Fong Y, Parisi A and Woo Y: The 30-year experience-a
meta-analysis of randomised and high-quality non-randomised studies
of hyperthermic intraperitoneal chemotherapy in the treatment of
gastric cancer. Eur J Cancer. 79:1–14. 2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Blum Murphy M, Ikoma N, Wang X, Estrella
J, Roy-Chowdhuri S, Das P, Minsky BD, Song S, Mansfield P, Ajani J
and Badgwell B: Phase I trial of hyperthermic intraperitoneal
chemoperfusion (HIPEC) with cisplatin, mitomycin, and paclitaxel in
patients with gastric adenocarcinoma and associated carcinomatosis
or positive cytology. Ann Surg Oncol. 27:2806–2811. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Chia CS, You B, Decullier E, Vaudoyer D,
Lorimier G, Abboud K, Bereder JM, Arvieux C, Boschetti G and Glehen
O: BIG RENAPE Group. Patients with peritoneal carcinomatosis from
gastric cancer treated with cytoreductive surgery and hyperthermic
intraperitoneal chemotherapy: Is cure a possibility? Ann Surg
Oncol. 23:1971–1979. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Yonemura Y, Ishibashi H, Hirano M,
Mizumoto A, Takeshita K, Noguchi K, Takao N, Ichinose M, Liu Y and
Li Y: Effects of neoadjuvant laparoscopic hyperthermic
intraperitoneal chemotherapy and neoadjuvant
intraperitoneal/systemic chemotherapy on peritoneal metastases from
gastric cancer. Ann Surg Oncol. 24:478–485. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Ikoma N, Chen HC, Wang X, Blum M, Estrella
JS, Fournier K, Mansfield P, Ajani J and Badgwell BD: Patterns of
initial recurrence in gastric adenocarcinoma in the era of
preoperative therapy. Ann Surg Oncol. 24:2679–2687. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ikoma N, Blum M, Chiang YJ, Estrella JS,
Roy-Chowdhuri S, Fournier K, Mansfield P, Ajani J and Badgwell BD:
Yield of staging laparoscopy and lavage cytology for radiologically
occult peritoneal carcinomatosis of gastric cancer. Ann Surg Oncol.
23:4332–4337. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Newhook TE, Agnes A, Blum M, Estrella JS,
Das P, Ho L, Ajani JA, Minsky BD, Mansfield P and Badgwell BD:
Laparoscopic hyperthermic intraperitoneal chemotherapy is safe for
patients with peritoneal metastases from gastric cancer and may
lead to gastrectomy. Ann Surg Oncol. 26:1394–1400. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Coccolini F, Cotte E, Glehen O, Lotti M,
Poiasina E, Catena F, Yonemura Y and Ansaloni L: Intraperitoneal
chemotherapy in advanced gastric cancer. Meta-analysis of
randomized trials. Eur J Surg Oncol. 40:12–26. 2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Yan TD, Black D, Sugarbaker PH, Zhu J,
Yonemura Y, Petrou G and Morris DL: A systematic review and
meta-analysis of the randomized controlled trials on adjuvant
intraperitoneal chemotherapy for resectable gastric cancer. Ann
Surg Oncol. 14:2702–2713. 2007.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Yang XJ, Huang CQ, Suo T, Mei LJ, Yang GL,
Chen FL, Zhou YF, Xiong B, Yonemura Y and Li Y: Cytoreductive
surgery and hyperthermic intraperitoneal chemotherapy improves
survival of patients with peritoneal carcinomatosis from gastric
cancer: Final results of a phase III randomized clinical trial. Ann
Surg Oncol. 18:1575–1581. 2011.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Badgwell B: Multimodality therapy of
localized gastric adenocarcinoma. J Natl Compr Canc Netw.
14:1321–1327. 2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Sugarbaker PH: Gastric cancer: Prevention
and treatment of peritoneal metastases. J Cancer Metastasis Treat.
4(7)2018.
|
|
22
|
Yu P, Ye Z, Dai G, Zhang Y, Huang L, Du Y
and Cheng X: Neoadjuvant systemic and hyperthermic intraperitoneal
chemotherapy combined with cytoreductive surgery for gastric cancer
patients with limited peritoneal metastasis: A prospective cohort
study. BMC Cancer. 20(1108)2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Beeharry MK, Zhang TQ, Liu WT and Gang ZZ:
Optimization of perioperative approaches for advanced and late
stages of gastric cancer: Clinical proposal based on literature
evidence, personal experience, and ongoing trials and research.
World J Surg Oncol. 18(51)2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Beeharry MK, Ni ZT, Yang ZY, Zheng YN,
Feng RH, Liu WT, Yan C, Yao XX, Li C, Yan M and Zhu ZG: Study
protocol of a multicenter phase III randomized controlled trial
investigating the efficiency of the combination of neoadjuvant
chemotherapy (NAC) and neoadjuvant laparoscopic intraperitoneal
hyperthermic chemotherapy (NLHIPEC) followed by R0 gastrectomy with
intraoperative HIPEC for advanced gastric cancer (AGC): Dragon II
trial. BMC Cancer. 20(224)2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Badgwell B, Blum M, Das P, Estrella J,
Wang X, Ho L, Fournier K, Royal R, Mansfield P and Ajani J: Phase
II trial of laparoscopic hyperthermic intraperitoneal
chemoperfusion for peritoneal carcinomatosis or positive peritoneal
cytology in patients with gastric adenocarcinoma. Ann Surg Oncol.
24:3338–3344. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Sarela AI, Miner TJ, Karpeh MS, Coit DG,
Jaques DP and Brennan MF: Clinical outcomes with laparoscopic stage
M1, unresected gastric adenocarcinoma. Ann Surg. 243:189–195.
2006.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Brenner H, Rothenbacher D and Arndt V:
Epidemiology of stomach cancer. Methods Mol Biol. 472:467–477.
2009.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Cappellani A, Zanghi A, Di Vita M, Zanet
E, Veroux P, Cacopardo B, Cavallaro A, Piccolo G, Lo Menzo E,
Murabito P and Berretta M: Clinical and biological markers in
gastric cancer: Update and perspectives. Front Biosci (Schol Ed).
2:403–412. 2010.PubMed/NCBI View
Article : Google Scholar
|
|
29
|
Feingold PL, Kwong ML, Sabesan A, Sorber R
and Rudloff U: Cytoreductive surgery and hyperthermic
intraperitoneal chemotherapy for gastric cancer and other less
common disease histologies: Is it time? J Gastrointest Oncol.
7:87–98. 2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Wu XJ, Yuan P, Li ZY, Bu ZD, Zhang LH, Wu
AW, Zong XL, Li SX, Shan F, Ji X, et al: Cytoreductive surgery and
hyperthermic intraperitoneal chemotherapy improves the survival of
gastric cancer patients with ovarian metastasis and peritoneal
dissemination. Tumor Biol. 34:463–469. 2013.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Yonemura Y, Kawamura T, Bandou E,
Takahashi S, Sawai T and Matsuki N: Treatment of peritoneal
dissemination from gastric cancer by peritonectomy and
chemohyperthermic peritoneal perfusion. Br J Surg. 92:370–375.
2005.PubMed/NCBI View
Article : Google Scholar
|
|
32
|
Takahashi T, Hagiwara A, Shimotsuma M,
Sawai T and Yamaguchi T: Prophylaxis and treatment of peritoneal
carcinomatosis: Intraperitoneal chemotherapy with mitomycin C bound
to activated carbon particles. World J Surg. 19:565–569.
1995.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Bryan ML, Fitzgerald NC, Levine EA, Shen
P, Stewart JH and Votanopoulos KI: Cytoreductive surgery with
hyperthermic intraperitoneal chemotherapy in sarcomatosis from
gastrointestinal stromal tumor. Am Surg. 80:890–895.
2014.PubMed/NCBI
|
|
34
|
Braeuer F, Fischer I, Brammen L, Pressl G,
Fuegger R, Rohregger K and Wundsam H: Outcome in patients treated
with cytoreductive surgery and HIPEC for gastric cancer with
peritoneal carcinomatosis. Anticancer Res. 40:2151–2156.
2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Bonnot PE, Piessen G, Kepenekian V,
Decullier E, Pocard M, Menuier B, Bereder JM, Abboud K, Marchal F,
Quenet F, et al: Cytoreductive surgery with or without hyperthermic
intraperitoneal chemotherapy for gastric cancer with peritoneal
metastases (CYTO-CHIP study): A propensity score analysis. J Clin
Oncol. 37:2028–2040. 2019.PubMed/NCBI View Article : Google Scholar
|
